Alternatives to Recursion Pharmaceuticals
30 tools that compete with or replace Recursion Pharmaceuticals. Ranked by direct product-type match — not generic category overlap.
Why people look for alternatives to Recursion Pharmaceuticals
The complaints that come up most often in public discussion — reviews, forums and community threads. Not our opinion, and not the vendor's marketing.
- Community discussion is almost entirely about the stock, not the platform or its scientific merit
- Retail shareholders repeatedly flag huge outstanding share count and ongoing executive selling
- No licensable product means outside researchers and developers cannot evaluate the AI stack
- Sentiment is heavily shaped by short-seller content and paid subscription promotions, not independent analysis
Drawn from 19 mentions across 1 sources · researched Oct 15, 2026.
In fairness: users also consistently praise rec-1245 phase 1 data showed well-tolerated safety and predictable pharmacokinetics with no dlts observed, and clinical-stage pipeline gives the ai platform narrative concrete, checkable evidence points. A complaint list is not a verdict — see the full picture on the Recursion Pharmaceuticals page.
Insilico Medicine
Generative AI drug discovery suite spanning target ID, molecule design, biologics and clinical trial prediction.
Owkin
Owkin's K Pro is an autonomous AI scientist for drug discovery and clinical trial decisions, built on multimodal patient data
Recursion
Clinical-stage techbio company pairing automated wet labs with AI models to discover and develop drugs.
Insitro
Causal AI drug discovery that pairs 20+ petabytes of cellular data with human genetics to find real disease targets
Exscientia
Recursion's AI drug discovery platform pairing 2M weekly wet-lab experiments with a 50+ PB proprietary dataset, now incorporating Exscientia.
Evotec
Evotec is a life-science partner running AI-assisted drug discovery and Just–Evotec Biologics manufacturing.
Nimbus Therapeutics
Clinical-stage biotech designing highly selective small-molecule drugs for oncology, immunology, and metabolic disease.
Schrodinger
Physics-based molecular simulation with AI for drug discovery and materials design.
BenevolentAI
BenevolentAI applies a decade-built biomedical knowledge graph to drug target discovery and repurposing for biopharma R&D teams.
SciSpace BioMed Agent
SciSpace BioMed Agent runs multi-omics, variant prioritization, and drug repurposing analysis from plain-language biomedical prompts.
Novaflow
Novaflow is an AI data analyst that runs scRNA-seq, spatial, and multi-omics pipelines from raw data to publication-ready figures and
CUREBench
CURE-Bench is an open-source benchmark grading AI therapeutic decision-making and software-engineering reasoning at scale.
DrugClaw
Open-source, self-hosted AI research assistant for drug discovery — molecular property prediction, virtual screening and PK/PD modeling on your own hardware.
Iktos
Iktos pairs generative AI for small-molecule design with AI retrosynthesis and robotic lab automation.
Quibim
Quibim turns MRI, CT and PET scans into cleared, quantitative imaging biomarkers for prostate, brain, liver, breast and lung.
Iambic Therapeutics
AI drug discovery company pairing Enchant v3 and NeuralPLexer models with a weekly high-throughput wet lab and a wholly owned clinical pipeline.
Cradle Bio
Cradle is an AI protein engineering platform that designs optimised variant plates from your own wet-lab results and feeds each round back into the models.
Dotmatics
Enterprise scientific intelligence platform whose Luma Agent plans, runs and documents R&D data analysis under human approval
Adaptyv
Automated cloud lab for protein validation — binding, expression and thermostability assays with data back in as little as 3 days
Algen Biotechnologies
AI-CRISPR target discovery platform pairing AlgenCRISPR gene modulation with the AlgenBrain foundation model for causal immunology and
HealthKey
AI patient identification for clinical trials: HealthKey scans your EHR daily and emails your team trial-eligible patients.
Delineate
Delineate assembles clinical pharmacology evidence into MBMA databases and models for dose optimization and go/no-go decisions.
Atlas Discovery
AI-native pharma company using autonomous agents to find new uses for existing drugs and predict patient drug response
BioStack Platforms
BioStack Platforms supplies structured clinical datasets and RL environments for healthcare AI teams.
Novelcare
Clinician-centered clinical trial matching that notifies your patients when a local, medically relevant study exists.
PicnicAI
PicnicAI turns patient health records into clinical research data and real-world evidence.
Frekil
Frekils is AI agents for real-world evidence studies — cohorts, SAPs and publication-ready statistics on your own clinical data.
Isomorphic Labs
AI drug discovery from Isomorphic Labs: predictive and generative models that design molecules and forecast drug performance.
Goodfire
Silico is Goodfire's mechanistic interpretability agent for understanding, debugging, and steering the internals of your AI models.
Flatiron Health
Oncology real-world evidence built from point-of-care patient data, with AI-powered analysis layered on top.
Frequently asked questions
What are the best alternatives to Recursion Pharmaceuticals?
We currently list 30 alternatives to Recursion Pharmaceuticals: Insilico Medicine, Owkin, Recursion, Insitro, Exscientia. Each is ranked by direct product-type match rather than generic category overlap.
How do you choose which Recursion Pharmaceuticals alternatives to show?
Alternatives are ranked by direct product-type match — tools that do the same job — not by shared category tags. Every listed tool is independently re-verified on a continuous cycle.